Differential downstream signaling in microglia lacking Alzheimer's-related TREM2 or its adaptor TYROBP/DAP12.

["Gabriela E Farias Quipildor", "Ramona Belfiore", "Khaled Althobaiti", "Zahra Najarzadeh", "Charles Glabe", "Benjamin P Readhead", "Sam Gandy", "Stephen R J Salton", "Michelle E Ehrlich"]
Molecular neurodegeneration advances 2026
Open on PubMed

UNLABELLED: Microglia, the primary immune cell in the brain, have multiple activation phenotypes involved in broad functions within the brain, playing roles in neurotoxicity/neuroprotection, release of inflammatory and anti-inflammatory cytokines, and in cell survival, proliferation, and phagocytosis. TREM2 and TYROBP form a transmembrane complex in microglia that modulates intracellular signaling networks, and these proteins are essential regulators of the transition from homeostatic to activated microglia. Recent findings support a TREM2-independent molecular signature that is involved in the early transition of homeostatic to disease-associated microglia (DAM), with the next sequential step of DAM activation from stage 1 to stage 2 being TREM2-dependent. However, the underlying mechanisms determining how TREM2 or TYROBP regulate these downstream phenotypes are largely unknown. We isolated primary microglia from C57BL/6 wild-type (WT) controls, Trem2 knock-out (KO), and Tyrobp KO mice at post-natal day 0-3. Cells were treated with Alzheimer's disease (AD)-relevant stimuli, such as amyloid beta (Aβ) oligomers or fibrils, or 'neuroinflammatory-like' stimuli, such as lipopolysaccharide (LPS). We explored protein and gene expression in the presence or absence of inhibitors of the TREM2/TYROBP downstream signaling pathway. We also performed a high-throughput Olink proteomic analysis of conditioned media from WT, Trem2 KO, and Tyrobp KO stimulated with either LPS or Aβ oligomers or fibrils. Our results show that the absence of either TREM2 or TYROBP is associated with increased basal levels of phosphorylated ERK in primary microglia compared to WT controls. In addition, Trem2 KO and Tyrobp KO cells show a less ramified cell morphology at baseline, as compared to WT microglia. Moreover, stimulating primary microglia with either Aβ oligomers or LPS leads to differential protein and gene expression in cells lacking TREM2 or TYROBP. The dysregulated downstream signal transduction and morphology in the absence of TREM2 or TYROBP suggest their essential roles not only in microglial homeostasis but also in their activation in response to different stimuli. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s44477-025-00012-x.

7 Figures Extracted
Fig. 1
Fig. 1 PMC
Functional disruptions of Trem2 KO and Tyrobp KO microglia at baseline, and upon stimulation. A) Representative images of CD68 (red), IL-6 (gree...
Fig. 2
Fig. 2 PMC
LPS stimulation fails to increase ERK phosphorylation in Trem2 KO or Tyrobp KO microglia. A) Western blot and densitometry quantification of p-E...
Fig. 3
Fig. 3 PMC
ERK activation differs in Trem2 KO and Tyrobp KO microglia after Aβ fibril stimulation. A) Western blot and densitometry quantification of p-ERK...
Fig. 4
Fig. 4 PMC
Syk inhibition decreased Erk phosphorylation at baseline in Tyrobp KO microglia, but not in Trem2 KO microglia. A) Western blot and densitometry...
Fig. 5
Fig. 5 PMC
Lack of TREM2 or TYROBP showed large-scale changes in microglial gene expression at baseline. A) Volcano plot analysis identified upregulated (yello...
Fig. 6
Fig. 6 PMC
Lipid signaling and inflammatory signature distinctions between Trem2 KO and Tyrobp KO microglia. A) Venn diagram of DEGs between LPS stimulatio...
Fig. 7
Fig. 7 PMC
Trem2 KO and Tyrobp KO show differential proteomic signatures for pro-inflammatory activation and ECM-sensing and remodeling. A) Heatmap of diffe...